What is the English name of Binimetinib and introduction to drug identification?

The English name of Bimetinib is Binimetinib. It is an oral small molecule MEK inhibitor. It is a targeted therapy drug and is used to treat certain types of malignant tumors, especially those related to activation of the RAS/RAF/MEK/ERK signaling pathway. The drug mainly inhibits tumor growth by inhibiting the activity of MEK1 and MEK2 protein kinases and blocking cell proliferation signals.

Binimetinib ’s drug identification information includes its generic name (Generic Name: Binimetinib), trade name (common brand name Mektovi®), molecular formula (C17H15BrF2N4O3) and its chemical structural formula. It is usually made in the form of tablets, with a common specification of 15 mg tablets, and is mostly packaged according to treatment courses. The drug was developed by Array BioPharma in the United States and later acquired by Novartis (Novartis). It has obtained marketing approval in many countries.

Binimetinib often combined with other targeted drugs such as entrectinib (Encorafenib), especially when treating patients with BRAF V600E or V600Kmutated unresectable or metastatic melanoma has good efficacy. Clinical studies have shown that the combination regimen can significantly improve the response rate and overall survival compared with monotherapy. Therefore, when doctors use this drug, they usually first confirm whether the patient has the corresponding mutation through genetic testing to ensure the effectiveness of the targeted therapy.

It should be noted that as a prescription drug, bimetinib must be administered under the guidance of an oncologist. Before taking medication, a detailed understanding of the patient's genetic background, liver and kidney function, and whether there are other comorbidities should be made to avoid drug interactions and serious adverse reactions. In addition, because it may cause side effects such as vision problems, increased creatinine, rash, diarrhea, etc., it is necessary to regularly review and monitor relevant indicators during use to ensure drug safety and stable efficacy.

Reference materials:https://www.drugs.com/